Veropharm Sees Sales Rise in H1, 2013

According to IMS Health, in compliance with the results of H1, 2013 Veropharm, the market leader in Russia for production of plasters and oncological medicines with production facilities in Belgorod, Voronezh and Pokrov and the product portfolio including more than 300 items, occupies the 6th position in the rating “Russian pharmaceutical manufacturers in production volume terms”. This is a good achievement for the company, which will certainly stimulate its further growth. 

© Eurasian chemical market, 2005-2021